<--- Back to Details
First PageDocument Content
Combination drugs / Asthma / Food and Drug Administration / Therapeutics / United States Public Health Service / Formoterol / Salmeterol / Fluticasone/salmeterol / Pharmaceutical industry / Pharmacology / Medicine / Pharmaceutical sciences
Date: 2014-05-11 01:07:11
Combination drugs
Asthma
Food and Drug Administration
Therapeutics
United States Public Health Service
Formoterol
Salmeterol
Fluticasone/salmeterol
Pharmaceutical industry
Pharmacology
Medicine
Pharmaceutical sciences

Whilst Tasmania has the highest rate of asthma in Australia, the forest industries continue to burn their waste and the Asthma Foundation (Tasmania) refuse to lobby on behalf of its members to stop the smoke at the sourc

Add to Reading List

Source URL: www.cleanairtas.com

Download Document from Source Website

File Size: 11,50 KB

Share Document on Facebook

Similar Documents

April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

DocID: 1voig - View Document

Initiating Coverage  December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

DocID: 1vapl - View Document

  Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

  Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

DocID: 1v3IN - View Document

Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

DocID: 1v3kf - View Document

Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

DocID: 1v0Hj - View Document